|
Volumn 6, Issue 3, 1999, Pages 233-240
|
HER-2 as a prognostic, predictive, and therapeutic target in breast cancer
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
DIAGNOSTIC VALUE;
DRUG TARGETING;
GENE EXPRESSION REGULATION;
HUMAN;
ONCOGENE NEU;
PROGNOSIS;
PROTEIN DETERMINATION;
REVIEW;
|
EID: 0032931395
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: 10.1177/107327489900600301 Document Type: Review |
Times cited : (27)
|
References (44)
|